GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Henan Lingrui Pharmaceutical Co Ltd (SHSE:600285) » Definitions » ROA %

Henan Lingrui Pharmaceutical Co (SHSE:600285) ROA % : 13.40% (As of Sep. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Henan Lingrui Pharmaceutical Co ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Henan Lingrui Pharmaceutical Co's annualized Net Income for the quarter that ended in Sep. 2024 was ¥643 Mil. Henan Lingrui Pharmaceutical Co's average Total Assets over the quarter that ended in Sep. 2024 was ¥4,800 Mil. Therefore, Henan Lingrui Pharmaceutical Co's annualized ROA % for the quarter that ended in Sep. 2024 was 13.40%.

The historical rank and industry rank for Henan Lingrui Pharmaceutical Co's ROA % or its related term are showing as below:

SHSE:600285' s ROA % Range Over the Past 10 Years
Min: 3.7   Med: 9.34   Max: 14.09
Current: 14.09

During the past 13 years, Henan Lingrui Pharmaceutical Co's highest ROA % was 14.09%. The lowest was 3.70%. And the median was 9.34%.

SHSE:600285's ROA % is ranked better than
92.35% of 1033 companies
in the Drug Manufacturers industry
Industry Median: 2.27 vs SHSE:600285: 14.09

Henan Lingrui Pharmaceutical Co ROA % Historical Data

The historical data trend for Henan Lingrui Pharmaceutical Co's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Henan Lingrui Pharmaceutical Co ROA % Chart

Henan Lingrui Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROA %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.07 9.60 9.96 11.44 12.46

Henan Lingrui Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
ROA % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.29 8.67 15.62 18.37 13.40

Competitive Comparison of Henan Lingrui Pharmaceutical Co's ROA %

For the Drug Manufacturers - Specialty & Generic subindustry, Henan Lingrui Pharmaceutical Co's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Henan Lingrui Pharmaceutical Co's ROA % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Henan Lingrui Pharmaceutical Co's ROA % distribution charts can be found below:

* The bar in red indicates where Henan Lingrui Pharmaceutical Co's ROA % falls into.


;
;

Henan Lingrui Pharmaceutical Co ROA % Calculation

Henan Lingrui Pharmaceutical Co's annualized ROA % for the fiscal year that ended in Dec. 2023 is calculated as:

ROA %=Net Income (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=568.109/( (4344.622+4771.917)/ 2 )
=568.109/4558.2695
=12.46 %

Henan Lingrui Pharmaceutical Co's annualized ROA % for the quarter that ended in Sep. 2024 is calculated as:

ROA %=Net Income (Q: Sep. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Sep. 2024 ))/ count )
=643.36/( (4713.972+4885.563)/ 2 )
=643.36/4799.7675
=13.40 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Sep. 2024) net income data. ROA % is displayed in the 30-year financial page.


Henan Lingrui Pharmaceutical Co  (SHSE:600285) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Sep. 2024 )
=Net Income/Total Assets
=643.36/4799.7675
=(Net Income / Revenue)*(Revenue / Total Assets)
=(643.36 / 3412.436)*(3412.436 / 4799.7675)
=Net Margin %*Asset Turnover
=18.85 %*0.711
=13.40 %

Note: The Net Income data used here is four times the quarterly (Sep. 2024) net income data. The Revenue data used here is four times the quarterly (Sep. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Henan Lingrui Pharmaceutical Co ROA % Related Terms

Thank you for viewing the detailed overview of Henan Lingrui Pharmaceutical Co's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


Henan Lingrui Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 59 Jiefang Chengguan Road, Xinxian, Xinyang, Henan, CHN, 465550
Henan Lingrui Pharmaceutical Co Ltd is a Chinese company engaged in the development, production, and distribution of pharmaceuticals. The Company's products include tablets, capsules, injections and other medicines.
Executives
Wu Xi Zhen Director
Ye Qiang senior management
Chen Yan Directors, senior managers
Wu Hui Bin senior management
Yu Peng Director
Zhao Zhi Jun Director
Li Lei senior management
Feng Guo Xin Directors, senior managers
Pan Zi Run Director
Li Jin Supervisors
Xiong Wei Zheng Director
Tang Wei Supervisors
Cheng Jian Jun Director
Zhang Jun Bing Director
Xia Hui senior management

Henan Lingrui Pharmaceutical Co Headlines

No Headlines